In this case, knockdown of CDK20 leads to G1 phase cell cycle arrest and decreased CDK2 phosphorylation, suppressing the growth of glioma cells in vivo, implicating CDK20 as an oncogene for this type of cancer. This evidence concerns the gene CDK20 and glioma.